
Extremely preterm infants often face challenges related to extubation, with up to 60% experiencing failure leading to increased mortality and morbidity. This multicentre, randomised trial aimed to assess whether higher nasal continuous positive airway pressure (nCPAP) levels (10 cmH2O) compared to standard levels (7 cmH2O) reduce extubation failure within 7 days. Of the 139 enrolled infants, those assigned to higher nCPAP experienced significantly lower extubation failure rates (35% vs. 57%). No significant differences in adverse events were noted. The findings suggest the potential benefits of higher nCPAP in reducing extubation failure in extremely preterm infants.
Like
Save
Share